Status Codes

HPUB: processing complete, entry on hold until publication
HOLD: processing complete, entry on hold until a certain date
PROC: to be processed
WAIT: processing started, waiting for author input to continue processing
AUTH: processed, waiting for author review and approval
AUCO: author corrections pending review
REPL: author sent new coordinates, entry to be reprocessed
POLC: waiting for a policy decision
REFI: re-refined entry, processing pending availability of primary publication
TRSF: entry transferred to another data repository
WDRN: unreleased deposition withdrawn

The PDB archive is updated with new entries and status information each Wednesday. Send release requests or citation updates via the OneDep communication page if you are a depositor of the inquired entry or to deposit-help@mail.wwpdb.org if you are a user.

4X73

Human GAR transformylase in complex with GAR and N-{4-[4-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)benzyl]benzoyl}-L-glutamic acid (AGF23)

Status: WDRN
Deposited: 2014-12-09
Deposition Author(s): Deis, S.M., Dann III, C.E.
Author Prerelease Sequence Status: HOLD FOR RELEASE

Search unreleased entries

wwPDB is transitioning to the extended 12-character PDB ID including a prefix pdb_(e.g. pdb_00001abc; learn more).

All PDB users, including software developers and journal editors, must transition to this format.

Start using extended IDs and PDBx/mmCIF data files today.

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.

Prepare Data

Validate Data

Deposit Data

Help and Resources

Status Codes

4X73

Human GAR transformylase in complex with GAR and N-{4-[4-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)benzyl]benzoyl}-L-glutamic acid (AGF23)